1. Huiseng Biotech Secures Tens of Millions in Financing to Develop Active Substances from Marine Microbial Strains

News on December 27: Huisbio (full name: Fujian Huisbio Biotechnology Co., Ltd.) recently received tens of millions in financing, led by Zhangzhou Industrial Guidance Sub-fund, Century Xintou Equity Investment Fund. This round of financing will be used to expand the production capacity of tobacco enzyme preparations and the market development of products such as probiotics.

2. Prosperity7 Leads the Round B Financing of Over 100 Million Yuan for Juhed Biotech

Shenzhen Cisgen BioTechnology Co., Ltd. (referred to as: Cisgen Bio) announced the successful completion of a Series B round of financing exceeding RMB 100 million. This round of financing was led by Prosperity7 Ventures, a growth fund under Aramco Ventures, with additional investment from existing shareholder Blue Capital. The company has launched methylation testing products for early screening of gynecological tumors and female reproductive microbiome testing products. Its core product, HEGONGKANG CISCER® (NMPA approval No. 20233400253), received regulatory approval from the China National Medical Products Administration and was launched in March this year.

3. Neurodome, Inc. Secures Tens of Millions in Pre-A Funding

Neurodome, Inc. Completes Tens of Millions of Yuan in Pre-A Round Financing, Led by Shantou Growth Fund and Yuanhe Origin Point, with Follow-on Investments from China-Singapore Group, Xi'an Finance, and Xi'an Talent Development Fund; Freeside and Shunwei Continue to Increase Investment. This Round of Financing Will Mainly Be Used to Iterate "Temporal Interference Stimulation" Technology and Accelerate Product Registration for Various Indications.

4. We Health Biomedical Completes Nearly 100 Million Yuan B1 Round Financing, Invested by Shanghai Qingchuang RuiZhi Group

We Health Biomedical, a brand in China specializing in genetic disease gene testing and tertiary prevention and control of birth defects, has recently announced the completion of a nearly 100-million-yuan Series B1 financing round, with investors including Shanghai Qingchuang Rongzhi Group and others. This round of financing will further solidify the company's product layout and registration applications in genetic disease gene testing and tertiary prevention and control of birth defects, as well as expand the company’s LDT laboratory presence across China. The company has consecutively completed five rounds of investment, with investors being prominent institutions such as Shengshan Capital, Matrix Partners China, Huayao Capital, and Qingchuang Rongzhi.

5. The Top Ten International Science and Technology News of 2023 Revealed

On December 25, the top ten international science and technology news stories of 2023, selected by the Science and Technology Daily and some academicians and media professionals, were announced.

The Top Ten International Science and Technology News of 2023 are:

· "Growing" Electrodes in Living Tissue

· Male Mice Produce Functional Egg Cells

· Reconstruction of the Double-Slit Experiment in the Time Dimension

· International Team Announces Epoch-Making Discovery of Gravitational Wave Background Radiation

· Single-Atom X-Ray Signal Detected for the First Time

· Completion of the Assembly and Analysis of the Human Y Chromosome

· Neural Network Designs New Proteins

· China's National Space Laboratory Officially Operational

· The Most Comprehensive Atlas of Human Brain Cells Released to Date

· Large Language Models Continuously Iterate and Upgrade

6. The 2023 DAMO Academy Young Scientist Award List Announced

The Organizing Committee of the 2023 DAMO Academy Young Orange Award has officially announced the 2023 DAMO Academy Young Orange Award list and the "Most Potential Award" list based on the award's regulations, following qualification reviews, expert panel correspondence reviews, expert panel on-site reviews, and expert panel final deliberations.

Note:1. Each winner of the Qingcheng Award will receive special support from Alibaba's public welfare fund.A discretionary bonus of 1 million.2. Each winner of the "Most Potential Award" in the Qingcheng Award will receive 100,000 yuan in special support from Alibaba's public welfare fund.Discretionary bonus.

This article is for academic sharing only. Please indicate the source for reprinting. If there is any infringement, please contact WeChat: bioonSir for deletion or modification!